Back / lumbar spine — all decisions

The Board denied service connection for bilateral hearing loss disability and remanded the claims for back, left lower extremity radiculopathy, and right lower extremity radiculopathy disabilities for readjudication with new evidence.

The Board denied several claims for increased ratings and service connection, but granted some reductions in rating that were improperly made.

The Board granted service connection for GERD, left wrist sprain, right knee strain, and degenerative disc disease of the lumbar spine. The claim for an increased rating for generalized anxiety disorder with depressive disorder was denied.

The Board remands the claim for a lumbar spine disability to obtain a new medical opinion addressing whether the Veteran's lumbar spine degenerative arthritis and spondylosis was caused or aggravated by his service-connected left knee chondromalacia with strain.

The Board granted service connection for left foot plantar fasciitis, right foot hallux valgus, and left foot hallux valgus. Service connection was also granted for the low back condition and a right shoulder condition. However, the claims for a neck condition and right hip condition were denied.

The Board remands the claim for a low back disability to obtain an adequate medical opinion that considers the Veteran's lay statements and in-service treatment records.

The Board denied the veteran's claims for earlier effective dates and higher ratings for various service-connected conditions, except for a few granted evaluations.

The Board remands the claims for service connection for hearing loss, psychiatric disorder, neck disorder, and radiculopathy of both upper and lower extremities to correct duty-to-assist errors.

The Board denied service connection for a traumatic brain injury (TBI), chronic disability manifested by dizziness, and other claimed disabilities as there was no evidence of current diagnoses or nexus to service.

The Board denied the veteran's claims for increased ratings for a low back disability, pseudofolliculitis barbae (PFB), and glaucoma.

The Board denied an initial disability rating in excess of 20 percent from May 11, 2017 prior to February 29, 2024, and in excess of 40 percent from February 29, 2024 for a service-connected lumbar spine disability.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) as his service-connected disabilities, while severe, do not render him unable to obtain or maintain a gainful occupation.

The Board remands the claims for service connection for low back condition and neck/upper back as further development is needed to obtain an adequate VA opinion.

The Board remands the claims for additional development, including obtaining private treatment records and scheduling VA examinations to assess the severity of the Veteran's disabilities from May 7, 2013, to August 5, 2019.

The Board denied service connection for a back disability, and remanded claims for respiratory condition, cataracts, diabetes mellitus, and hypertension.

The Board remands the claims for further development, specifically to obtain private treatment records from Premier Medical Group.

The Board remands the claim for an increased disability rating for arthritis with spondylosis and spurring of the lumbar spine due to a need for further development, including obtaining a retrospective opinion and addressing the ameliorative effects of medication.

The veteran withdrew the appeal for service connection for a low back condition, left knee condition, and right knee condition.

The Board granted a 30 percent initial disability rating for the removal of the uterus due to cervical dysplasia and awarded special monthly compensation based on anatomical loss of use of a creative organ.

The Board granted service connection for cervical and lumbar spine disabilities, headaches, and bilateral lower extremity radiculopathy. It also dismissed the claims for higher ratings of reactive airway disease, allergic rhinitis, and PTSD, denied service connection for CFS and TBI, and granted a 30% rating for IBS.